Navigation Links
Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions
Date:5/23/2013

of tests, to determine if they actually need to undergo these often debilitating and costly treatments. We believe that ultimately the extension of that knowledge via social media educational resources will spare thousands of women the unnecessary toxic effects of chemotherapy, and will spare society the burden of administering ineffective treatments"

Genomic testing looks at the activity of groups of genes within tumor tissue to provide a more comprehensive view of the specific cancer. Agendia's MammaPrint® genomic test (part of the Symphony panel of tests) can, for example, determine if a woman with early stage breast cancer is definitively at low risk or high risk of recurrence. According to the recently published RASTER study, 97% of women identified as low risk by MammaPrint® and who chose not to have chemotherapy were disease-free at five years. 

About Agendia:

Agendia is a leading molecular diagnostic company that develops and markets paraffin-based (FFPE) genomic diagnostic products. Agendia's breast cancer Symphony suite was developed using unbiased gene selection, analyzing the complete human genome, ensuring 100% definitive results for cancer patients. Together, the Symphony tests help physicians determine a patient's individual risk for metastasis, which patients will benefit from chemo, hormonal or combination therapy, and which patients can instead be treated with less arduous and less costly methods. www.agendia.com

Additional information for breast cancer patients and their circles of support is available at www.KnowYourBreastCancer.com and www.Facebook.com/SymphonySisterhood


'/>"/>
SOURCE Agendia
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Agendia Appoints Dr. Neil M. Barth MD, FACP, as Chief Medical Officer
2. Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
3. Agendia Brings Together Thought Leaders in Molecular Diagnostics and Medical Oncology
4. Agendia Earns ISO Certification for Facilities in Amsterdam and Irvine
5. Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
6. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. TMA Launches Physician Services Organization for Patient Care
8. Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services
9. Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site
10. WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile
11. Research-based Pharmaceutical Industry Launches Do You Mind? Campaign to Fight Mental and Neurological Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014 Apnea Sciences ( www.apneasciences.com ... in Aliso Viejo , California.  ... the tremendous growth and worldwide expansion, a new facility ... SnoreRx, the anti snore cure have exceeded our expectations ... "We are now in 23 countries and will be ...
(Date:12/22/2014)... 22, 2014   TRU-D SmartUVC LLC, producers ... robot, announced today that the General Services Administration has ... 2019.   This newly formed agreement will ... of government purchasers, including Department of Veteran Affairs and ... Security contacts purchasing solutions for the Ebola effort in ...
(Date:12/22/2014)... 22, 2014  ConvaTec, a privately-held medical products and ... appointed Interim Chief Executive Officer of the company, effective ... Ken Berger .  "The Board of Directors of ConvaTec ... over the past three years," said Magnus Lundberg ... are confident that the company is well positioned for ...
Breaking Medicine Technology:TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
(Date:12/24/2014)... 25, 2014 Epigenetics finds applications in ... including oncology, drug discovery, developmental biology, and research for ... one of the most widely used techniques for the ... the prevalence of cancer is rapidly growing worldwide. In ... million cancer deaths, and 32.6 million people living with ...
(Date:12/24/2014)... 24, 2014 Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ... tort litigation currently underway in Pennsylvania’s Philadelphia Court of ... December 24, 2014, court documents indicate that 1,183 claims ... individuals who developed gynecomastia (male breast growth) and other ... Court indicates that this represents an increase of more ...
(Date:12/24/2014)... York, New York (PRWEB) December 24, 2014 ... ( http://www.xareltolawsuit2015.com/ ) that allege the blood thinner ... complications has outlined a leadership structure for the ... Order dated December 17th, the Court plans to ... the parties and also plans on appointing a ...
(Date:12/24/2014)... (PRWEB) December 25, 2014 The report ... 2023” focuses on the current treatment landscape, unmet needs, ... market. Stivarga is a drug which is used in ... is orally administered and is also prescribed to patients ... which is FDA approved is a multi-kinase inhibitor and ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, 2014 (HealthDay News) -- ... year will be allowed to donate blood in the United States, ... on donations from men who have sex with men. The ... a new draft guidance in early 2015 that would ultimately open ... is changing its policy based on data from other countries that ...
Breaking Medicine News(10 mins):Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:FDA to Lift Ban on Blood Donations by Gay Men 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 3
... (HealthDay News) -- Long-term survival rates are low for intensive ... arrest, a new study finds. Canadian researchers looked at ... arrest while in the ICUs of four Alberta hospitals. Of ... for one year, and 16 percent for five years. ...
... that an infant with an older sibling with autism also ... 10 percent, is substantially higher at approximately 19 percent, a ... Davis MIND Institute has found. While the study found a ... found an even more elevated risk of recurrence of over ...
... seemingly approaching a day when they will be able to ... cells. You need nerves or pancreas, bone or skin? With ... laboratory tissue culture dish promises to yield therapeutic wonders. But ... potential problem: Any remaining embryonic stem cells - those that ...
... Standing water is a breeding ground for mosquitoes that can ... many urban families don,t take simple steps such as dumping ... Last summer, researchers polled 242 urban residents to find out ... risks posed by standing water, a mosquito breeding ground. Researchers ...
... , FRIDAY, Aug. 12 (HealthDay News) -- The ... U.S. Treasury Department today awarded $185 million to 13 states ... Affordable Insurance Exchanges -- a cornerstone of President Obama,s health ... proposed three rules for administering the plan, which will include ...
... 12 (HealthDay News) -- Patients who take antipsychotic ... complications, researchers have found. Known as "metabolic ... antipsychotic drugs. For example, up to 60 percent ... cholesterol, 40 percent have high blood pressure and ...
Cached Medicine News:Health News:Recurrence risk of autism in younger siblings higher than thought 2Health News:Recurrence risk of autism in younger siblings higher than thought 3Health News:Stanford discovery may eliminate potentially lethal side effect of stem cell therapy 2Health News:Stanford discovery may eliminate potentially lethal side effect of stem cell therapy 3Health News:Stanford discovery may eliminate potentially lethal side effect of stem cell therapy 4Health News:Get Rid of Standing Water to Protect From Mosquitoes 2Health News:Feds Outline Rules for States' Insurance Exchanges 2Health News:Patients Taking Antipsychotics Urged to Get Routine Physicals 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: